Dowden Nathan J 4
4 · Entrada Therapeutics, Inc. · Filed Sep 30, 2024
Insider Transaction Report
Form 4
Dowden Nathan J
President & COO
Transactions
- Sale
Common Stock
2024-09-26$16.00/sh−847$13,552→ 125,149 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024.